- Philstar.com
- The Philippine Star
- Pilipino Star Ngayon
- The Freeman
- Pang-Masa
- Banat
- Interaksyon
- Coupons
SUPPORT PHILSTAR
About Us |
Contact Us |
Advertise |
Privacy Policy |
Member Agreement |
Copyright Notice
Copyright © 2026. Philstar Global Corp. All Rights Reserved
X
+ Follow DR. GERRY TAN Tag
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1312532
[Title] => Managing diabetes
[Summary] => The rapid growth of diabetes cases in the country shouldn't come as a surprise for a carbohydrate-loading nation.
[DatePublished] => 2014-04-14 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1489320
[AuthorName] => Maria Eleanor E. Valeros
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
[1] => Array
(
[ArticleID] => 378942
[Title] => Landmark diabetes trial seen to control blood sugar better
[Summary] =>
You are what you eat! Whatever you feed yourself will likely speak highly or poorly of you. Like words that come out of your mouth which might be taken one day against you, what you had indulged in gastronomically during the holidays - oh, all of those tempting sweets and starchies and lots of other sinful goodies - could be detrimental to the activities of the endocrine system.
[DatePublished] => 2007-01-08 00:00:00
[ColumnID] => 133560
[Focus] => 0
[AuthorID] => 1489320
[AuthorName] => Maria Eleanor E. Valeros
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
[2] => Array
(
[ArticleID] => 375197
[Title] => Drug found to delay type 2 diabetes
[Summary] =>
Type 2 diabetes patients can now look forward to the potential prevention of complications of said disease after an international study found out that rosiglitazone maleate has successfully reduced the risk of monotherapy failure in people who have the disease.
Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with rosiglitazone maleate reduced the risk of monotherapy failure in people with type 2 diabetes by 32 percent compared to metformin, and 63 percent compared to glyburide at five years.
[DatePublished] => 2006-12-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Cebu News
[SectionUrl] => cebu-news
[URL] =>
)
)
)
DR. GERRY TAN
Array
(
[results] => Array
(
[0] => Array
(
[ArticleID] => 1312532
[Title] => Managing diabetes
[Summary] => The rapid growth of diabetes cases in the country shouldn't come as a surprise for a carbohydrate-loading nation.
[DatePublished] => 2014-04-14 00:00:00
[ColumnID] => 0
[Focus] => 0
[AuthorID] => 1489320
[AuthorName] => Maria Eleanor E. Valeros
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
[1] => Array
(
[ArticleID] => 378942
[Title] => Landmark diabetes trial seen to control blood sugar better
[Summary] =>
You are what you eat! Whatever you feed yourself will likely speak highly or poorly of you. Like words that come out of your mouth which might be taken one day against you, what you had indulged in gastronomically during the holidays - oh, all of those tempting sweets and starchies and lots of other sinful goodies - could be detrimental to the activities of the endocrine system.
[DatePublished] => 2007-01-08 00:00:00
[ColumnID] => 133560
[Focus] => 0
[AuthorID] => 1489320
[AuthorName] => Maria Eleanor E. Valeros
[SectionName] => Freeman Cebu Lifestyle
[SectionUrl] => cebu-lifestyle
[URL] =>
)
[2] => Array
(
[ArticleID] => 375197
[Title] => Drug found to delay type 2 diabetes
[Summary] =>
Type 2 diabetes patients can now look forward to the potential prevention of complications of said disease after an international study found out that rosiglitazone maleate has successfully reduced the risk of monotherapy failure in people who have the disease.
Results from ADOPT (A Diabetes Outcome Progression Trial) demonstrated that initial treatment with rosiglitazone maleate reduced the risk of monotherapy failure in people with type 2 diabetes by 32 percent compared to metformin, and 63 percent compared to glyburide at five years.
[DatePublished] => 2006-12-15 00:00:00
[ColumnID] => 133272
[Focus] => 0
[AuthorID] =>
[AuthorName] =>
[SectionName] => Cebu News
[SectionUrl] => cebu-news
[URL] =>
)
)
)
abtest
By Maria Eleanor E. Valeros | April 14, 2014 - 12:00am
By Maria Eleanor E. Valeros | January 8, 2007 - 12:00am
December 15, 2006 - 12:00am
Recommended
Vice President Sara Duterte secured 49 government contracts worth around P35 million while serving as the second highest official of the country, the bulk of which was with the local government of Davao City where her brother Sebastian is mayor, a prosecution witness testified yesterday.
23 hours ago
Sen. Rodante Marcoleta is no longer inclined to participate in Vice President Sara Duterte’s impeachment trial amid ongoing discussions to count out absent senators like him in the voting threshold to convict.
23 hours ago
For four years, Vice President Sara Duterte has occupied the country’s second-highest office with vast resources at her disposal.
23 hours ago
A company that Vice President Sara Duterte declared as one of her business interests won nearly P36 million in government contracts during her term, almost a third from the Davao City government, a procurement official testified on Tuesday, September 22.
1 day ago
VP Sara declared GenCorp in her SALN. Her brother says Davao City never knew.
1 day ago
Lotto Sep 23, 2026
EZ2/LVM - 4 8
SUERTRES - 4 1 4
4D Lotto - 0 7 0 1
6/45 Mega Lotto - 44 5 4 40 45 7
P71,193,623.00
6/55 Grand Lotto - 29 47 22 32 50 46
P219,836,261.00
Forex
February 12, 2018
- 12:00 am
- 12:00 am
1$ : P51.66








